Anjum Naz, Tabish Hussain, Debdas Saha, Bani Hembrom P, Rajat Choudhuri, Anjana Basu Ghosh Dastidar
Department of Anaesthesiology and Intensive Care, R.G. Kar Medical College and Hospital, Kolkata, West Bengal, India.
Department of Functional Genomics, Institute of Genomics and Integrative Biology, New Delhi, India.
Avicenna J Med. 2015 Jul-Sep;5(3):67-73. doi: 10.4103/2231-0770.160231.
Alpha-2 (α2) adrenergic receptor agonists, clonidine and dexmedetomidine, are widely used as adjuvants during anesthesia for analgesic, sedative, sympatholytic, and cardiovascular stabilizing effects.
We compared effects of clonidine and dexmedetomidine (as propofol adjuvants) on intra-operative hemodynamics, recovery time, and postoperative cognitive function impairment.
Forty-five American Society of Anesthesiologists I and II patients, scheduled for laparoscopic cholecystectomy were divided into three groups (n = 15). Group C patients received bolus of clonidine 3 μg/kg followed by a continuous infusion; Group D patients received dexemedetomidine 1 μg/kg and a continuous infusion; and Group P patients received a bolus of normal saline followed by an infusion. Intra-operative mean arterial pressure (MAP) and pulse rate (PR) were measured throughout the surgery. Bispectral index was maintained at 55 ± 5 by titrating propofol infusion rate. The time between the interruption of anesthesia and eye opening (recovery time) was measured. Cognitive function was assessed using short mental status questionnaire at 15, 30, 45, and 60 min postoperatively.
The sympathetic response to laryngoscopy and extubation on MAP and PR were significantly reduced with the use of clonidine and dexmedetomidine (P < 0.05). The recovery was delayed (P < 0.05) with both the drug combinations and it was more pronounced with dexmedetomidine (P < 0.05). Dexmedetomidine group showed cognitive impairment in a postoperative period lasting up to an hour.
When co-administered with propofol, both clonidine, and dexmedetomidine attenuate sympathetic response to laryngoscopy and extubation but cause delay in the recovery from anesthesia. Dexmedetomidine causes impairment of postoperative cognitive functions.
α2肾上腺素能受体激动剂可乐定和右美托咪定作为辅助药物,因其具有镇痛、镇静、抗交感神经及心血管稳定作用,在麻醉过程中被广泛应用。
我们比较了可乐定和右美托咪定(作为丙泊酚辅助药物)对术中血流动力学、苏醒时间及术后认知功能障碍的影响。
45例拟行腹腔镜胆囊切除术的美国麻醉医师协会I级和II级患者被分为三组(n = 15)。C组患者静脉注射3μg/kg可乐定后持续输注;D组患者静脉注射1μg/kg右美托咪定后持续输注;P组患者静脉注射生理盐水后持续输注。术中持续监测平均动脉压(MAP)和心率(PR)。通过调整丙泊酚输注速率使脑电双频指数维持在55±5。记录麻醉停止至睁眼的时间(苏醒时间)。术后15、30、45和60分钟使用简易精神状态问卷评估认知功能。
使用可乐定和右美托咪定后,喉镜检查和拔管时MAP和PR的交感神经反应显著降低(P < 0.05)。两种药物组合均使苏醒延迟(P < 0.05),且右美托咪定更明显(P < 0.05)。右美托咪定组在术后长达1小时内出现认知功能障碍。
与丙泊酚合用时,可乐定和右美托咪定均可减弱喉镜检查和拔管时的交感神经反应,但会导致麻醉苏醒延迟。右美托咪定可引起术后认知功能障碍。